{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T12:29:10Z","timestamp":1788092950868,"version":"build-2803163510"},"reference-count":39,"publisher":"Impact Journals, LLC","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,4,4]]},"DOI":"10.18632\/oncotarget.15169","type":"journal-article","created":{"date-parts":[[2017,2,8]],"date-time":"2017-02-08T17:56:15Z","timestamp":1486576575000},"page":"22700-22715","source":"Crossref","is-referenced-by-count":17,"title":["A NOTCH-sensitive uPAR-regulated oncolytic adenovirus effectively suppresses pancreatic tumor growth and triggers synergistic anticancer effects with gemcitabine and nab-paclitaxel"],"prefix":"10.18632","volume":"8","author":[{"given":"Ana","family":"Mato-Berciano","sequence":"first","affiliation":[{"name":"Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Raras (CIBERER), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Raimondi","sequence":"additional","affiliation":[{"name":"Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Raras (CIBERER), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Victoria","family":"Maliandi","sequence":"additional","affiliation":[{"name":"Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Raras (CIBERER), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Alemany","sequence":"additional","affiliation":[{"name":"Institut Catal\u00e0 d'Oncologia-IDIBELL. L'Hospitalet de Llobregat, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lluis","family":"Montoliu","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Raras (CIBERER), Barcelona, Spain"},{"name":"Centro Nacional de Biotecnologia (CNB-CSIC), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Fillat","sequence":"additional","affiliation":[{"name":"Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Raras (CIBERER), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,2,7]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nrgastro.2009.89","article-title":"Pancreatic cancer: molecular pathogenesis and new therapeutic targets","volume":"6","author":"Lemoine","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nature02009","article-title":"Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis","volume":"425","author":"Warshaw","year":"2003","journal-title":"Nature"},{"key":"3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1593\/neo.05607","article-title":"Aberrant Wnt\/beta-catenin signaling in pancreatic adenocarcinoma","volume":"8","author":"Monga","year":"2006","journal-title":"Neoplasia"},{"key":"4","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1535-6108(03)00140-5","article-title":"Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis","volume":"3","author":"Schmid","year":"2003","journal-title":"Cancer Cell"},{"key":"5","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1242\/dev.078634","article-title":"A Notch-dependent molecular circuitry initiates pancreatic endocrine and ductal cell differentiation","volume":"139","author":"Sander","year":"2012","journal-title":"Development"},{"key":"6","doi-asserted-by":"crossref","first-page":"e91983","DOI":"10.1371\/journal.pone.0091983","article-title":"The Notch pathway is important in maintaining the cancer stem cell population in pancreatic cancer","volume":"9","author":"Simeone","year":"2014","journal-title":"PLoS One"},{"key":"7","doi-asserted-by":"crossref","first-page":"18913","DOI":"10.1073\/pnas.0810097105","article-title":"Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice","volume":"105","author":"Maitra","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"8","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1242\/dev.063610","article-title":"Notch signaling: simplicity in design, versatility in function","volume":"138","author":"Lendahl","year":"2011","journal-title":"Development"},{"key":"9","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrclinonc.2015.53","article-title":"Pancreatic cancer: from state-of-the-art treatments to promising novel therapies","volume":"12","author":"Hidalgo","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"10","first-page":"555","article-title":"A phase I\/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma","volume":"9","author":"Freeman","year":"2003","journal-title":"Clin Cancer Res"},{"key":"11","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1593\/neo.81674","article-title":"Urokinase-type plasminogen activator receptor transcriptionally controlled adenoviruses eradicate pancreatic tumors and liver metastasis in mouse models","volume":"11","author":"Fillat","year":"2009","journal-title":"Neoplasia"},{"key":"12","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12943-015-0413-2","article-title":"AduPARE1A and gemcitabine combined treatment trigger synergistic antitumor effects in pancreatic cancer through NF-kappaB mediated uPAR activation","volume":"14","author":"Fillat","year":"2015","journal-title":"Mol Cancer"},{"key":"13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.scr.2013.09.008","article-title":"uPAR-controlled oncolytic adenoviruses eliminate cancer stem cells in human pancreatic tumors","volume":"12","author":"Fillat","year":"2014","journal-title":"Stem Cell Res"},{"key":"14","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1073\/pnas.0611092104","article-title":"Cooperative assembly of higher-order Notch complexes functions as a switch to induce transcription","volume":"104","author":"Blacklow","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"15","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1182\/blood.V86.2.624.bloodjournal862624","article-title":"A conserved TATA-less proximal promoter drives basal transcription from the urokinase-type plasminogen activator receptor gene","volume":"86","author":"Blasi","year":"1995","journal-title":"Blood"},{"key":"16","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/bfgp\/elp031","article-title":"Boundaries in vertebrate genomes: different solutions to adequately insulate gene expression domains","volume":"8","author":"Montoliu","year":"2009","journal-title":"Brief Funct Genomic Proteomic"},{"key":"17","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.1140871","article-title":"Developmentally regulated activation of a SINE B2 repeat as a domain boundary in organogenesis","volume":"317","author":"Glass","year":"2007","journal-title":"Science"},{"key":"18","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/bies.20059","article-title":"Prospects and implications of using chromatin insulators in gene therapy and transgenesis","volume":"26","author":"Farrell","year":"2004","journal-title":"Bioessays"},{"key":"19","doi-asserted-by":"crossref","first-page":"10127","DOI":"10.1158\/0008-5472.CAN-06-2744","article-title":"Effective treatment of tumors with strong beta-catenin\/T-cell factor activity by transcriptionally targeted oncolytic herpes simplex virus vector","volume":"66","author":"Martuza","year":"2006","journal-title":"Cancer Res"},{"key":"20","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/mt.2013.93","article-title":"Enhanced CRAd activity using enhancer motifs driven by a nucleosome positioning sequence","volume":"21","author":"Podhajcer","year":"2013","journal-title":"Mol Ther"},{"key":"21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.canlet.2013.01.054","article-title":"Notch signaling pathway targeted therapy suppresses tumor progression and metastatic spread in pancreatic cancer","volume":"335","author":"Rajeshkumar","year":"2013","journal-title":"Cancer Lett"},{"key":"22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1124\/mol.61.1.105","article-title":"IkappaB kinase activation is involved in regulation of paclitaxel-induced apoptosis in human tumor cell lines","volume":"61","author":"Fan","year":"2002","journal-title":"Mol Pharmacol"},{"key":"23","first-page":"167","article-title":"Targeting transcription factor NF-kappaB to overcome chemoresistance and radioresistance in cancer therapy","volume":"1805","author":"Sethi","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.pan.2013.11.011","article-title":"Notch pathway activation is associated with pancreatic cancer treatment failure","volume":"14","author":"Park","year":"2014","journal-title":"Pancreatology"},{"key":"25","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/gt.2011.141","article-title":"The oncolytic adenovirus AdDeltaDelta enhances selective cancer cell killing in combination with DNA-damaging drugs in pancreatic cancer models","volume":"18","author":"Hallden","year":"2011","journal-title":"Gene Ther"},{"key":"26","first-page":"6229","article-title":"Adenovirus type 5 E1A sensitizes hepatocellular carcinoma cells to gemcitabine","volume":"63","author":"Hung","year":"2003","journal-title":"Cancer Res"},{"key":"27","doi-asserted-by":"crossref","first-page":"e46617","DOI":"10.1371\/journal.pone.0046617","article-title":"Adenovirus-mediated sensitization to the cytotoxic drugs docetaxel and mitoxantrone is dependent on regulatory domains in the E1ACR1 gene-region","volume":"7","author":"Hallden","year":"2012","journal-title":"PLoS One"},{"key":"28","doi-asserted-by":"publisher","first-page":"15703","DOI":"10.18632\/oncotarget.7310","article-title":"The E1B19K-deleted oncolytic adenovirus mutant AdDelta19K sensitizes pancreatic cancer cells to drug-induced DNA-damage by down-regulating Claspin and Mre11","volume":"7","author":"Hallden","year":"2016","journal-title":"Oncotarget"},{"key":"29","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1038\/onc.2010.335","article-title":"Low-dose paclitaxel synergizes with oncolytic adenoviruses via mitotic slippage and apoptosis in ovarian cancer","volume":"29","author":"McNeish","year":"2010","journal-title":"Oncogene"},{"key":"30","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.molonc.2014.12.007","article-title":"Paclitaxel resistance increases oncolytic adenovirus efficacy via upregulated CAR expression and dysfunctional cell cycle control","volume":"9","author":"Syed","year":"2015","journal-title":"Mol Oncol"},{"key":"31","article-title":"A novel CDC25B promoter based oncolytic adenovirus inhibited growth of orthotopic human pancreatic tumors in different preclinical models","author":"Podhajcer","year":"2015","journal-title":"Clin Cancer Res"},{"key":"32","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/bjc.2013.415","article-title":"Stromal disrupting effects of nab-paclitaxel in pancreatic cancer","volume":"109","author":"Prados","year":"2013","journal-title":"Br J Cancer"},{"key":"33","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s13402-011-0049-1","article-title":"Characterization of human pancreatic orthotopic tumor xenografts suitable for drug screening","volume":"34","author":"Mazo","year":"2011","journal-title":"Cell Oncol (Dordr)"},{"key":"34","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12885-015-1249-2","article-title":"Human pancreatic cancer stem cells are sensitive to dual inhibition of IGF-IR and ErbB receptors","volume":"15","author":"Mazo","year":"2015","journal-title":"BMC Cancer"},{"key":"35","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0002-9440(10)65567-8","article-title":"Comparative phenotypic studies of duct epithelial cell lines derived from normal human pancreas and pancreatic carcinoma","volume":"153","author":"Tsao","year":"1998","journal-title":"Am J Pathol"},{"key":"36","doi-asserted-by":"crossref","first-page":"14354","DOI":"10.1073\/pnas.96.25.14354","article-title":"Positional enhancer-blocking activity of the chicken beta-globin insulator in transiently transfected cells","volume":"96","author":"Felsenfeld","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"37","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1242\/jcs.115.6.1295","article-title":"p65-NFkappaB synergizes with Notch to activate transcription by triggering cytoplasmic translocation of the nuclear receptor corepressor N-CoR","volume":"115","author":"Bigas","year":"2002","journal-title":"J Cell Sci"},{"key":"38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Talalay","year":"1984","journal-title":"Adv Enzyme Regul"},{"key":"39","doi-asserted-by":"publisher","first-page":"6179","DOI":"10.18632\/oncotarget.3350","article-title":"Late-phase miRNA-controlled oncolytic adenovirus for selective killing of cancer cells","volume":"6","author":"Fillat","year":"2015","journal-title":"Oncotarget"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.15169","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T20:58:07Z","timestamp":1658609887000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.15169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,7]]},"references-count":39,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2017,4,4]]}},"alternative-id":["15169","28186974"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.15169","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,7]]}}}